OBJECTIVES: To investigate the potential use of Ki-67 and pronuclear cell antigen (PCNA) as indicators of recurrent cholesteatoma. MATERIAL AND METHODS: Patients who had been diagnosed with cholesteatoma and who had undergone canal wall-down mastoidectomy were included in this study. Subjects were divided into two groups: recurrent and non-recurrent (i.e., cases without recurrence for at least 2 years). Ossicular pathologies were recorded. Histopathologic specimens were stained for Ki-67 and PCNA and the percentages of stained cells were calculated. RESULTS: Neither group demonstrated a significant difference in terms of total Ki-67 per cell, Ki-67-stained cell counts, Ki-67-staining percentages, total PCNA per cell, PCNA-stained cell counts, or PCNA-staining percentages (p>0.05). No significant relationship was noted between the staining percentages for either Ki-67 or PCNA and the incudostapedial involvement (p>0.05); however, a significant relationship was noted between Ki-67 staining and malleus involvement (p<0.05). CONCLUSION: Although the recurrent and non-recurrent cholesteatoma groups showed no significant differences in terms of the percentages of stained cells for either Ki-67 or PCNA, we detected high Ki-67 staining in the malleus involvement group. We concluded that cell-proliferation markers could not be defined as indicators of recurrence of cholesteatoma, but they could be defined as indicators of destructive patterns of this disease.
OBJECTIVES: To investigate the potential use of Ki-67 and pronuclear cell antigen (PCNA) as indicators of recurrent cholesteatoma. MATERIAL AND METHODS:Patients who had been diagnosed with cholesteatoma and who had undergone canal wall-down mastoidectomy were included in this study. Subjects were divided into two groups: recurrent and non-recurrent (i.e., cases without recurrence for at least 2 years). Ossicular pathologies were recorded. Histopathologic specimens were stained for Ki-67 and PCNA and the percentages of stained cells were calculated. RESULTS: Neither group demonstrated a significant difference in terms of total Ki-67 per cell, Ki-67-stained cell counts, Ki-67-staining percentages, total PCNA per cell, PCNA-stained cell counts, or PCNA-staining percentages (p>0.05). No significant relationship was noted between the staining percentages for either Ki-67 or PCNA and the incudostapedial involvement (p>0.05); however, a significant relationship was noted between Ki-67 staining and malleus involvement (p<0.05). CONCLUSION: Although the recurrent and non-recurrent cholesteatoma groups showed no significant differences in terms of the percentages of stained cells for either Ki-67 or PCNA, we detected high Ki-67 staining in the malleus involvement group. We concluded that cell-proliferation markers could not be defined as indicators of recurrence of cholesteatoma, but they could be defined as indicators of destructive patterns of this disease.
Authors: T Paunesku; S Mittal; M Protić; J Oryhon; S V Korolev; A Joachimiak; G E Woloschak Journal: Int J Radiat Biol Date: 2001-10 Impact factor: 2.694
Authors: G Choufani; R Ghanooni; C Decaestecker; K Delbrouck; P Simon; M P Schüring; Y Zick; S Hassid; H J Gabius; R Kiss Journal: Laryngoscope Date: 2001-09 Impact factor: 3.325
Authors: G Choufani; V Mahillon; C Decaestecker; T Lequeux; A Danguy; I Salmon; H J Gabius; S Hassid; R Kiss Journal: Laryngoscope Date: 1999-11 Impact factor: 3.325
Authors: Kelly G P Kerckhoffs; Maarten B J Kommer; Thom H L van Strien; Simeon J A Visscher; Hanneke Bruijnzeel; Adriana L Smit; Wilko Grolman Journal: Laryngoscope Date: 2015-09-25 Impact factor: 3.325
Authors: Elena Cantone; Claudio Di Nola; Eugenio De Corso; Michele Cavaliere; Giusi Grimaldi; Anna Rita Fetoni; Gaetano Motta Journal: J Pers Med Date: 2022-08-21